Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Synthesis and biological activity of new resveratrol derivative and molecular docking: dynamics studies on NFkB.

Banaganapalli B, Mulakayala C, D G, Mulakayala N, Pulaganti M, Shaik NA, Cm A, Rao RM, Al-Aama JY, Chitta SK.

Appl Biochem Biotechnol. 2013 Dec;171(7):1639-57. doi: 10.1007/s12010-013-0448-z. Epub 2013 Aug 29.

PMID:
23990478
2.

Synthesis and evaluation of resveratrol derivatives as new chemical entities for cancer.

Mulakayala C, Babajan B, Madhusudana P, Anuradha CM, Rao RM, Nune RP, Manna SK, Mulakayala N, Kumar CS.

J Mol Graph Model. 2013 Apr;41:43-54. doi: 10.1016/j.jmgm.2013.01.005. Epub 2013 Feb 4.

PMID:
23500626
3.

Experimental and computational studies on newly synthesized resveratrol derivative: a new method for cancer chemoprevention and therapeutics?

Banaganapalli B, Mulakayala C, Pulaganti M, Mulakayala N, Anuradha CM, Suresh Kumar C, Shaik NA, Yousuf Al-Aama J, Gudla D.

OMICS. 2013 Nov;17(11):568-83. doi: 10.1089/omi.2013.0014. Epub 2013 Sep 17.

PMID:
24044363
4.
5.

Resveratrol induces apoptosis of human nasopharyngeal carcinoma cells via activation of multiple apoptotic pathways.

Huang TT, Lin HC, Chen CC, Lu CC, Wei CF, Wu TS, Liu FG, Lai HC.

J Cell Physiol. 2011 Mar;226(3):720-8. doi: 10.1002/jcp.22391.

PMID:
20717957
6.

A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells.

Jeong SH, Jo WS, Song S, Suh H, Seol SY, Leem SH, Kwon TK, Yoo YH.

Biochem Pharmacol. 2009 Apr 15;77(8):1337-47. doi: 10.1016/j.bcp.2009.01.002. Epub 2009 Jan 20.

PMID:
19426672
7.

Influence of glucuronidation and reduction modifications of resveratrol on its biological activities.

Lu DL, Ding DJ, Yan WJ, Li RR, Dai F, Wang Q, Yu SS, Li Y, Jin XL, Zhou B.

Chembiochem. 2013 Jun 17;14(9):1094-104. doi: 10.1002/cbic.201300080. Epub 2013 May 23.

PMID:
23703900
8.

Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells.

Benitez DA, Hermoso MA, Pozo-Guisado E, Fernández-Salguero PM, Castellón EA.

Prostate. 2009 Jul 1;69(10):1045-54. doi: 10.1002/pros.20953.

PMID:
19301309
9.

Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents.

Ruan BF, Lu X, Tang JF, Wei Y, Wang XL, Zhang YB, Wang LS, Zhu HL.

Bioorg Med Chem. 2011 Apr 15;19(8):2688-95. doi: 10.1016/j.bmc.2011.03.001. Epub 2011 Mar 5.

PMID:
21440448
10.

Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogs.

Mazué F, Colin D, Gobbo J, Wegner M, Rescifina A, Spatafora C, Fasseur D, Delmas D, Meunier P, Tringali C, Latruffe N.

Eur J Med Chem. 2010 Jul;45(7):2972-80. doi: 10.1016/j.ejmech.2010.03.024. Epub 2010 Mar 25.

11.

Novel Aza-resveratrol analogs: synthesis, characterization and anticancer activity against breast cancer cell lines.

Siddiqui A, Dandawate P, Rub R, Padhye S, Aphale S, Moghe A, Jagyasi A, Venkateswara Swamy K, Singh B, Chatterjee A, Ronghe A, Bhat HK.

Bioorg Med Chem Lett. 2013 Feb 1;23(3):635-40. doi: 10.1016/j.bmcl.2012.12.002. Epub 2012 Dec 11.

PMID:
23273518
12.

Resveratrol enhances ultraviolet B-induced cell death through nuclear factor-kappaB pathway in human epidermoid carcinoma A431 cells.

Roy P, Madan E, Kalra N, Nigam N, George J, Ray RS, Hans RK, Prasad S, Shukla Y.

Biochem Biophys Res Commun. 2009 Jun 26;384(2):215-20. doi: 10.1016/j.bbrc.2009.04.100. Epub 2009 May 3. Erratum in: Biochem Biophys Res Commun. 2010 May 7;395(3):448. Madan, Esha [added].

PMID:
19397895
13.

PKC activation by resveratrol derivatives with unsaturated aliphatic chain.

Pany S, Majhi A, Das J.

PLoS One. 2012;7(12):e52888. doi: 10.1371/journal.pone.0052888. Epub 2012 Dec 21.

14.
15.

Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells.

Yu H, Pan C, Zhao S, Wang Z, Zhang H, Wu W.

Biomed Pharmacother. 2008 Jul-Aug;62(6):366-72. Epub 2007 Oct 22.

PMID:
17988825
16.

G2/M cell cycle arrest and induction of apoptosis by a stilbenoid, 3,4,5-trimethoxy-4'-bromo-cis-stilbene, in human lung cancer cells.

Lee EJ, Min HY, Joo Park H, Chung HJ, Kim S, Nam Han Y, Lee SK.

Life Sci. 2004 Oct 22;75(23):2829-39.

PMID:
15464834
17.
18.

Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells.

Lee SJ, Kim MM.

Life Sci. 2011 Mar 14;88(11-12):465-72. doi: 10.1016/j.lfs.2011.01.005. Epub 2011 Jan 14.

PMID:
21238464
19.

Resveratrol inhibits proliferation and promotes apoptosis of neuroblastoma cells: role of sirtuin 1.

Pizarro JG, Verdaguer E, Ancrenaz V, Junyent F, Sureda F, Pallàs M, Folch J, Camins A.

Neurochem Res. 2011 Feb;36(2):187-94. doi: 10.1007/s11064-010-0296-y. Epub 2010 Oct 24.

PMID:
20972827
20.

Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging.

Gautam SC, Xu YX, Dumaguin M, Janakiraman N, Chapman RA.

Bone Marrow Transplant. 2000 Mar;25(6):639-45.

Supplemental Content

Support Center